semaglutide gi obstruction class action in louisiana glp-1 gastrointestinal lawsuit glp-1 gastric intestinal obstruction attorney in louisiana Ozempic GLP-1 Lawsuit & Gastroparesis-mvanhaasteren.nl Weight Loss Drugs Lawsuit |

Can skincare readdress the balance?

While Wegovy and Zepbound added non-weight-loss indications, this second payer, instead, moved to outright rejecting claims between 70% and 80% of the time

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or pharmacies could compound drugs that were essentially copies of either semaglutide (available under the brand names Ozempic, Rybelsus, and Wegovy) and tirzepatide (available under the brand names Mounjaro, and Zepbound).

Retatrutide (-24.2%) vs Mounjaro (-22.5%): 3 receptors vs 2

Understanding these distinctions helps you choose the right treatment pathway for your health objectives

| Direct-to-consumer health and wellness company Ro will now offer access to lower-priced, single-dose vials of weight loss drug Zepbound through a new partnership with Eli Lilly.